KFx Medical Corporation Receives 510k Clearance for Knotless Tissue Fixation

Share Article

KFx Medical Corporation, a developer of minimally invasive percutaneous repair systems for rotator cuff repair announced today that it has received FDA clearance to market its SutureCross™ Knotless Anatomic Fixation System.

News Image
This is the most exciting new development for rotator cuff repair in a decade. I’m proud to have been part of the development process.

San Diego, CA August 10, 2006 -- KFx Medical Corporation, a developer of minimally invasive percutaneous repair systems for rotator cuff repair announced today that it has received FDA clearance to market its SutureCross™ Knotless Anatomic Fixation System.

Dr. Joseph C. Tauro, one of the pioneers in arthroscopic cuff repair in private practice at Ocean County Sports Medicine in Toms River, NJ and Assistant Clinical Professor of Orthopedic Surgery at New Jersey Medical School and Chairman of the KFx Scientific Advisory Board said, “This is the most exciting new development for rotator cuff repair in a decade. I’m proud to have been part of the development process.”

“KFx’s unique double row SutureCross™ system has been in development for a number of years,” said Tate Scott, President and CEO. “We will first use this system at select Centers of Excellence around the country prior to our full market launch.”

Over four million people seek medical advice for shoulder pain every year; torn rotator cuffs alone account for more than 500,000 surgeries annually and have traditionally required many weeks of rehabilitation. Traditional minimally invasive techniques, although promising - patients typically experience less pain and regain full range of motion more quickly - require surgeons to have advanced arthroscopic skills. In contrast, KFx provides simple minimally invasive products for surgeons that enable a more anatomical repair for the patient.

About KFx Medical Corporation

Headquartered in Carlsbad, Calif., KFx Medical Corporation was founded in 2003 to develop clinically relevant solutions to rotator cuff repair. The company is privately held – Investors include Charter Life Sciences, Arboretum Ventures, Montreux Equity Partners, and MB Venture Partners.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

W. Tate Scott
Visit website